Healthcare -
Biotechnology - NASDAQ - US
$ 0.8465
3.31 %
$ 306 M
Market Cap
-1.14
P/E
LXRX - CASH FROM OPERATIONS
Cash from Operations LXRX - Lexicon Pharmaceuticals, Inc.
-162 M
LAST VALUE
-36.40%
2 YEAR CAGR
-1.73%
5 YEAR CAGR
-5.92%
10 YEAR CAGR